ArticleFrontiers in oncology2023

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.

York E Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.